OTraces’ TME Cancer Blood Test Presentation at Innovation Challenge Spurs Investor Interest from JP Morgan Healthcare Conference Participants
11 janv. 2018 13h39 HE
|
OTraces, Inc.
SAN FRANCISCO and BALTIMORE, Jan. 11, 2018 (GLOBE NEWSWIRE) -- OTraces Inc., a Sykesville, Maryland-based cancer diagnostics company with a unique patented and patent-pending blood test which...
Beyond Liquid Biopsy: Blood Test Can Boost Cancer Detection, Diagnosis With the Tumor Microenvironment (TME), Early Validation Results Reveal (White Paper)
15 juin 2017 09h53 HE
|
OTraces, Inc.
SYKESVILLE, MD--(Marketwired - Jun 15, 2017) - OTraces Inc., a biotech company developing blood tests for cancer diagnosis, announces the development of the first blood test to access the...